ROS can initiate inflammatory responses, cause DNA damage, and lead to oncogenic mutations such as those in BRAF and RAS genes, thereby increasing the aggressiveness and progression of thyroid cancer [6,7,8,9,35,36]. Here, BRAF is linked to thyroid gland carcinoma.